Company News

This press release is posted as a service by Angioplasty.Org



Toshiba Showcases Aquilion Workflow and Storage Enhancements at RSNA

CHICAGO, Nov. 29, 2006 – Satisfying the growing demand for tools that optimize data acquisition and transfer for improved efficiency and faster diagnosis, Toshiba America Medical Systems, Inc. is showcasing its suite of workflow and storage enhancements for its Aquilion™ CT systems at the Radiological Society of North America’s (RSNA) annual meeting in Chicago, Nov. 26-Dec. 1 in Toshiba booth #1129 (South Building, Hall A).

Enhancements include a new V3 software release on the CT console that enables faster scanning and data analysis, resulting in improved efficiency and more accurate diagnoses. Toshiba also is demonstrating the new Automated PhaseXact™ software (an additional component of the SURECardio™ package) that automatically locates the optimal phase of the heartbeat assuring the best image quality, decreasing image reconstruction time by at least 50 percent and reducing storage requirements. Advanced rendering and analysis in seconds is now possible with V3’s enhanced DICOM data transfers. This new option enables data transfer at up to 60 images-per-second.

The new SUREPlaque™ advanced software application available on the Vital Images Vitrea® workstation allows clinicians to easily visualize and characterize plaques that are likely to cause acute coronary events. These enhancements are especially important for the Aquilion 64 model because of the larger volumes of data provided.

Additionally, new storage solutions optimized for multi-slice CT systems allow easy, economical storage of thin-slice data – delivering a true modality archive developed in partnership with McKesson Corporation without slowing down PACS (Picture Archiving and Communication System) infrastructure.

“Toshiba continually strives to raise the standard of care, and we are pleased that clinicians and patients alike will benefit from the industry’s highest performing line of CT systems,” said Doug Ryan, senior director, CT Business Unit, Toshiba. “These enhancements to our Aquilion systems provide clinicians with the level of confidence they need to optimize diagnosis and enhance overall departmental workflow and efficiency.” Aquilion 64

Featuring the most advanced multislice CT technologies available, the Aquilion 64 is built on Toshiba's unique 64-row Quantum detector, volumetric imaging capabilities and advanced software applications. The Aquilion is the world’s only true volumetric 64 CT system with 64 detector channels, 3-D cone beam algorithms and volume reconstruction. At the heart of the Aquilion 64 is its superior multi-detector design, which produces high-speed, high-resolution imaging with superior low-contrast resolution with lower dose. The Quantum detector enables the Aquilion CT scanner to acquire 64 simultaneous slices of 0.5 mm with each 350-millisecond gantry revolution. The result is precise isotropic imaging of any region of the body during a single breath-hold. Aquilion 64 CFX

Aquilion 64 CFX sets a new standard in cardiac CT. The Aquilion 64 CFX easily captures precise, motion-free images of the heart and coronary arteries to identify soft plaque and measure coronary blockages, which can detect signs of disease at its earliest stages and reduce the need for high-risk interventional procedures.

The Aquilion 64 CFX’s advanced multi-detector design produces unsurpassed low-contrast resolution with lower dose, critical for detection, quantification and characterization of soft plaque and vessel remodeling.

About Toshiba
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corp., an independent group company of Toshiba Corp., is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, Cath & EP Labs, X-ray, Ultrasound, Nuclear Medicine, MRI and information systems. Toshiba Corp. is a leader in information and communications systems, electronic components, consumer products, and power systems. Toshiba has approximately 161,000 employees worldwide and annual sales of $54 billion.

Aquilion™ is a trademark of Toshiba Medical Systems Corporation.

Source: Toshiba America Medical Systems, Inc.

Angioplasty.Org Home •  PatientCenter

this press release is posted as a reader service by Angioplasty.org,
an editorially independent informational health site
which has received unrestricted educational grants from
Medtronic plc, TCROSS NEWS, Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY
All content, including text, photos and video
©Copyright Venture Digital LLC 1996-2021